Pink SheetThe China State Drug Administration's Center for Drug Evaluation (CDE) has released its latest list of new drugs awarded priority approval reviews, which shows that eight out of the 12 products so des
ScripChina led the charge for Takeda Pharmaceutical Co. Ltd. in emerging markets in the fiscal nine months to Dec. 31 with 8% growth, and the Japanese company has already been speeding up its developme
ScripTakeda Pharmaceutical Co. Ltd. already appears to have a firm candidate in mind for a planned acquisition in an undisclosed emerging market, given remarks made by chief financial officer James Kehoe
ScripWhen top executives at Guangdong Techpool Bio-Pharma Co. Ltd. were drawing up plans for the firm’s future direction, they paid a visit to Harvard Business School Professor Robert S. Kaplan, who is